CA3076450A1 - Biomarker - Google Patents
Biomarker Download PDFInfo
- Publication number
- CA3076450A1 CA3076450A1 CA3076450A CA3076450A CA3076450A1 CA 3076450 A1 CA3076450 A1 CA 3076450A1 CA 3076450 A CA3076450 A CA 3076450A CA 3076450 A CA3076450 A CA 3076450A CA 3076450 A1 CA3076450 A1 CA 3076450A1
- Authority
- CA
- Canada
- Prior art keywords
- chromosome
- nucleic acids
- interactions
- probe
- interaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762566756P | 2017-10-02 | 2017-10-02 | |
| US62/566,756 | 2017-10-02 | ||
| PCT/GB2018/052808 WO2019069067A1 (en) | 2017-10-02 | 2018-10-01 | BIOMARKER |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3076450A1 true CA3076450A1 (en) | 2019-04-11 |
Family
ID=63834322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3076450A Pending CA3076450A1 (en) | 2017-10-02 | 2018-10-01 | Biomarker |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12006547B2 (OSRAM) |
| EP (1) | EP3692168A1 (OSRAM) |
| JP (2) | JP2020537514A (OSRAM) |
| KR (1) | KR102762920B1 (OSRAM) |
| CN (1) | CN111344415B (OSRAM) |
| AU (1) | AU2018344573B2 (OSRAM) |
| CA (1) | CA3076450A1 (OSRAM) |
| MY (1) | MY200184A (OSRAM) |
| SG (1) | SG11202002503TA (OSRAM) |
| WO (1) | WO2019069067A1 (OSRAM) |
| ZA (1) | ZA202001821B (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2604247B (en) * | 2019-09-11 | 2025-07-02 | Oxford BioDynamics PLC | Diagnostic chromosome marker |
| GB202016176D0 (en) * | 2020-10-12 | 2020-11-25 | Oxford BioDynamics PLC | Disease marker |
| AU2022206099B2 (en) * | 2021-01-07 | 2023-08-10 | Oxford BioDynamics PLC | Chromosome interactions |
| CN117203350A (zh) * | 2021-01-07 | 2023-12-08 | 牛津生物动力公共有限公司 | 染色体相互作用 |
| CN113035298B (zh) * | 2021-04-02 | 2023-06-20 | 南京信息工程大学 | 递归生成大阶数行限制覆盖阵列的药物临床试验设计方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2116280A1 (en) * | 1993-03-05 | 1994-09-06 | Marcy E. Macdonald | Huntingtin dna, protein and uses thereof |
| BRPI0611702B1 (pt) * | 2005-07-04 | 2015-05-19 | Univ Erasmus Medical Ct | Captura e caracterização de cromatina co-localizada (4c) |
| GB0810051D0 (en) * | 2008-06-02 | 2008-07-09 | Oxford Biodynamics Ltd | Method of diagnosis |
| JP5503942B2 (ja) * | 2009-10-30 | 2014-05-28 | シスメックス株式会社 | 疾患の罹患の判定方法 |
| WO2012159025A2 (en) * | 2011-05-18 | 2012-11-22 | Life Technologies Corporation | Chromosome conformation analysis |
| US11795496B2 (en) | 2015-06-24 | 2023-10-24 | Oxford BioDynamics PLC | Epigenetic chromosome interactions |
| WO2017001568A1 (en) | 2015-07-01 | 2017-01-05 | Universitat De Lleida | Treatment and prevention of amyotrophic lateral sclerosis |
| JP7045086B2 (ja) | 2016-12-23 | 2022-03-31 | オックスフォード バイオダイナミックス パブリック リミテッド カンパニー | 分類法 |
-
2018
- 2018-10-01 WO PCT/GB2018/052808 patent/WO2019069067A1/en not_active Ceased
- 2018-10-01 SG SG11202002503TA patent/SG11202002503TA/en unknown
- 2018-10-01 US US16/652,959 patent/US12006547B2/en active Active
- 2018-10-01 EP EP18785703.2A patent/EP3692168A1/en active Pending
- 2018-10-01 AU AU2018344573A patent/AU2018344573B2/en active Active
- 2018-10-01 MY MYPI2020001473A patent/MY200184A/en unknown
- 2018-10-01 KR KR1020207012372A patent/KR102762920B1/ko active Active
- 2018-10-01 JP JP2020518706A patent/JP2020537514A/ja active Pending
- 2018-10-01 CA CA3076450A patent/CA3076450A1/en active Pending
- 2018-10-01 CN CN201880074086.9A patent/CN111344415B/zh active Active
-
2020
- 2020-03-23 ZA ZA2020/01821A patent/ZA202001821B/en unknown
-
2023
- 2023-09-07 JP JP2023145557A patent/JP7701419B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7701419B2 (ja) | 2025-07-01 |
| US12006547B2 (en) | 2024-06-11 |
| KR102762920B1 (ko) | 2025-02-04 |
| NZ762713A (en) | 2025-03-28 |
| JP2023182591A (ja) | 2023-12-26 |
| KR20200058527A (ko) | 2020-05-27 |
| AU2018344573A1 (en) | 2020-04-09 |
| JP2020537514A (ja) | 2020-12-24 |
| WO2019069067A1 (en) | 2019-04-11 |
| CN111344415A (zh) | 2020-06-26 |
| CN111344415B (zh) | 2024-04-30 |
| US20200407790A1 (en) | 2020-12-31 |
| AU2018344573B2 (en) | 2020-09-17 |
| ZA202001821B (en) | 2022-10-26 |
| SG11202002503TA (en) | 2020-04-29 |
| MY200184A (en) | 2023-12-12 |
| EP3692168A1 (en) | 2020-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7701419B2 (ja) | バイオマーカー | |
| CA3078198A1 (en) | Pool type liquid metal fast spectrum reactor using a printed circuit heat exchanger connection to the power conversion system | |
| JP2020537514A5 (OSRAM) | ||
| US11535893B2 (en) | Typing method | |
| JP2025108590A (ja) | 診断用染色体マーカー | |
| US20240068032A1 (en) | Disease marker | |
| AU2021283746A1 (en) | Detecting a chromosome conformation as marker for fibrosis, e.g. scleroderma | |
| HK40031541A (en) | Biomarker | |
| HK40031541B (zh) | 生物标志物 | |
| HK40076364A (en) | Diagnostic chromosome marker | |
| HK40017704A (en) | Typing method for the diagnosis of alzheimer's disease | |
| HK40017704B (en) | Typing method for the diagnosis of alzheimer's disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20230927 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20240903 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD Year of fee payment: 6 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240926 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240926 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240926 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20241230 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250211 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20250924 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251201 |